JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
Acorda Provides 2018 Highlights and 2019 Guidance at J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
Acorda Therapeutics, Inc. (ACOR) PT Lowered to $19 at JPMorgan
-
-
-
-
-
-
-
Acorda Provides Financial and Pipeline Update for Second Quarter 2016
-
-
-
-
-
-
-
Acorda Therapeutics (ACOR) Enters Agreement to Acquire Biotie Therapies (BITI)
-
-
-
-
-
-
-
Market Wrap: Markets Fail to Hold Gains as China Cuts Rates; Best Buy has Strong Q2; Oshkosh Get Major Army Contract
-
-
-
-
-
-
-
JPMorgan Downgraded Several Biotech Stocks (ACOR, ALTH, AMAG, AMGN & VPHM)
-
-
-
-
-
-
-
Acorda Therapeutics (ACOR) Provides '09 Business and Pipeline Update
-
288,336 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

